GRAYSCALE BITCOIN CASH TR by Grayscale Bitcoin Cash Trust (BCH) Azioni (OTC: BCHG)

Ultime notizie per GRAYSCALE BITCOIN CASH TR by Grayscale Bitcoin Cash Trust (BCH) (OTC:BCHG) Azioni

GRAYSCALE BITCOIN CASH TR by Grayscale Bitcoin Cash Trust (BCH)

WIIM

DADA

Dada Nexus shares are trading lower. The company reported Q3 financial results.

ICAD

Icad shares are trading lower after the company reported worse-than-expected Q3 revenue results.

B of A Securities analyst Ronald Epstein maintains Rocket Lab USA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RKLB#NASDAQ">RKLB</a>) with a Buy and raises the price target from $10 to $30.

News

Price Target

Analyst Ratings

RKLB

B of A Securities Maintains Buy on Rocket Lab USA, Raises Price Target to $30

Trading Ideas

HTOO

Fusion Fuel Green Shares Halted On Circuit Breaker To The Upside, Stock Now Up 106.9%

RBC Capital analyst Sean Dodge maintains OptimizeRx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPRX#NASDAQ">OPRX</a>) with a Outperform and lowers the price target from $14 to $7.

OPRX

RBC Capital Maintains Outperform on OptimizeRx, Lowers Price Target to $7

GORV

Lazydays Holdings Shares Halted On Circuit Breaker To The Upside, Stock Now Up 112%

B of A Securities analyst Tal Liani maintains Cisco Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) with a Buy and raises the price target from $60 to $72.

CSCO

B of A Securities Maintains Buy on Cisco Systems, Raises Price Target to $72

ADAP

Adaptimmune Therapeutics shares are trading lower. The company reported Q3 financial results.

<a href="https://www.wsj.com/business/boeing-hires-northrop-executive-to-revamp-pentagon-projects-d64dab73?mod=latest_headlines">https://www.wsj.com/business/boeing-hires-northrop-executive-to-revamp-pentagon-projects-d64dab73?mod=latest_headlines</a>
<a href="https://www.wsj.com/market-data/quotes/BA">Boeing</a> has poached an executive from defense rival <a href="https://www.wsj.com/market-data/quotes/NOC">Northrop Grumman</a> to run its Phantom Works division, which oversees research efforts for its Pentagon business and is involved in bidding for U.S. government projects.
Colin Miler, a former Air Force commander who oversaw aeronautics engineering at Northrop, will take over the division, the jet maker told employees on Thursday. The Phantom Works division is also being combined into a single business unit. It currently is divided into separate organizations within Boeing's defense business.&nbsp;

Management

'Boeing Hires Northrop Executive To Revamp Pentagon Projects; Aerospace Giant Has Been Losing Billions On Military Contracts' - WSJ

RBC Capital analyst Luca Issi maintains 4D Molecular Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FDMT#NASDAQ">FDMT</a>) with a Outperform and lowers the price target from $40 to $39.

FDMT

RBC Capital Maintains Outperform on 4D Molecular Therapeutics, Lowers Price Target to $39

RBC Capital analyst Ben Hendrix reiterates Addus HomeCare (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADUS#NASDAQ">ADUS</a>) with a Outperform and maintains $136 price target.

Reiteration

ADUS

RBC Capital Reiterates Outperform on Addus HomeCare, Maintains $136 Price Target

Nu Holdings Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NU#NYSE">NU</a>) shares are trading lower Thursday after the company reported third-quarter financial results late Wednesday. Here&#8217;s <a href="https://www.benzinga.com/news/earnings/24/11/41955291/warren-buffett-backed-bank-nu-holdings-posts-q3-results-eps-in-line-revenues-beat-estimates">what you need to know.</a>
What To Know: Nu Holdings, a Brazilian digital bank backed by Warren Buffett, posted earnings of 11 cents per share, matching analyst expectations, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a> Revenue for the quarter was $2.94 billion, beating the expected $2.85 billion. The company&#8217;s top-line results were up from $2.14 billion in the same period last year.
In terms of customer growth, Nu Holdings added 5.2 million customers, bringing its global customer base up to 109.7 million as of Sept. 30. Nu&#8217;s customer base grew 23% year-over-year. 
The company&#8217;s Monthly Average Revenue per Active Customer (ARPAC) rose to $11 in the third quarter, while the cost to serve each customer remained low at 70 cents.
&#8220;Our third quarter 2024 underscores the strength of our business model, demonstrating top-line growth and sustained profitability,&#8221; said David Vélez, Nubank&#8217;s founder and CEO.
Following the report, multiple analysts <a href="https://www.benzinga.com/analyst-stock-ratings">adjusted price targets</a>. Susquehanna analyst James Friedman raised his price target from $16 to $18, maintaining a Positive rating on the stock. Similarly, Keybanc analyst Alex Markgraff raised his target from $15 to $17, keeping an Overweight rating. Goldman Sachs also maintained a Buy rating and raised its target from $17 to $19.
NU Price Action: Nu Holdings shares were down 8.34% at $14.34 at the time of writing, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro.</a>
<figure class="wp-block-image size-large is-resized"><a href="https://benzinga.slack.com/archives/D072651PB4K/p1727794380964569"><img loading="lazy" decoding="async" width="1024" height="542" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/14095323/NU-1024x542.png" alt="" class="wp-image-648145" style="width:407px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/14095323/NU-1024x542.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/14095323/NU-300x159.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/14095323/NU-768x407.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/14095323/NU.png 1161w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/11/41975042/nice-beats-q3-estimates-on-strong-sales-raises-outlook">Nice Beats Q3 Estimates On Strong Sales, Raises Outlook</a></li>
</ul>
Image via Blog Nu Mexico.

Earnings

Movers

Nu Holdings Shares Are Trading Down Today: What's Going On?

CAPR

Capricor Therapeutics shares are trading higher after Cantor Fitzgerald maintained an Overweight rating on the stock and raised its price target from $25 to $30.

RBC Capital analyst Elvira Scotto maintains Archrock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AROC#NYSE">AROC</a>) with a Outperform and raises the price target from $26 to $27.

AROC

RBC Capital Maintains Outperform on Archrock, Raises Price Target to $27

<a href="https://www.theverge.com/2024/11/14/24296295/google-gemini-app-iphone-ios-ai" title="https://www.theverge.com/2024/11/14/24296295/google-gemini-app-iphone-ios-ai">https://www.theverge.com/2024/11/14/24296295/google-gemini-app-iphone-ios-ai</a>

AAPL

GOOG

GOOGL

'Google's Gemini AI Now Has Its Own iPhone App; Gemini Live Is Also Here To Chat With All You iOS Users' - The Verge

Brett (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">BRETT</a>), the meme coin dubbed &#8216;Pepe&#8217;s best friend,&#8217; is rallying, with traders speculating a Coinbase listing might be <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41945111/pepe-listed-on-robinhood-coinbase-reaches-new-all-time-high-on-44-gain-traders-speculate-about-dogecoin-like-run">in the making</a>.
What Happened: Brett is competing with several medium-sized meme coins, which have all seen strong rallies in light of Bitcoin breaking new all-time highs.
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>Brett (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">BRETT</a>)</td>
<td> $0.146</td>
<td>$1.46 billion</td>
<td> +14.3%</td>
<td> +57.8%</td>
</tr>
<tr>
<td>Dogwifhat (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">WIF</a>)</td>
<td>&nbsp;$3.95</td>
<td>$3.95 billion</td>
<td> +8.0%</td>
<td> +67.4%</td>
</tr>
<tr>
<td>Popcat (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">POPCAT</a>)</td>
<td> $1.76 </td>
<td>$1.76 billion</td>
<td> +8.7%</td>
<td>&nbsp;+15.2%</td>
</tr>
<tr>
<td>Pepe (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">PEPE</a>)</td>
<td>$0.00002203</td>
<td>$22 billion</td>
<td>+17.3%</td>
<td>+109%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Crypto trader Crash <a href="https://x.com/CrashiusClay69/status/1856889873833046295">believes</a> Brett has the potential to overtake Dogwifhat, which is already listed on Coinbase, forecasting that Brett could reach two to six times WIF's current valuation.
Another trader, Momin, noted Brett's proximity to its all-time highs and speculated that, following Coinbase's recent addition of two meme coins, Brett could be next. 
Crash <a href="https://x.com/CrashiusClay69/status/1856802996757106755">agreed</a>, anticipating increased speculative interest in Brett as Coinbase's next listing.
Another trader, Composite Trader, described Brett's pattern as one of the strongest accumulation charts, <a href="https://x.com/Larskooistra_/status/1857055345929003212">saying</a> that a rounded-bottom formation, with no residual demand or sell-side liquidity, signals a bullish trend and a possible breakout.
He predicts it is time for Brett to complete its beta train duty and the "range will break towards the upside and will start to trend to new highs."
Community News: Alchemy Pay recently <a href="https://x.com/AlchemyPay/status/1857000968899940645">added</a> Brett to its on-ramp, enabling fiat purchases. During the last week, RocketX Mega DEX also listed Brett, <a href="https://x.com/RocketXexchange/status/1854856400100352417">offering</a> trading pairs with Bitcoin, Ethereum, Solana and over 20,000 tokens across 170+ blockchains.
What&#8217;s Next: The influence of meme coins is expected to be thoroughly explored at Benzinga&#8217;s upcoming <a href="https://www.benzinga.com/events/digital-assets/agenda/" target="_blank" rel="noreferrer noopener">Future of Digital Assets</a> event on Nov. 19.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41497079/trader-shares-3-point-strategy-to-win-with-meme-coins-heres-where-dogecoin-shiba-inu-come-">Trader Shares 3-Point Strategy To Win With Meme Coins—Here&#8217;s Where Dogecoin, Shiba Inu Come In</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BRETT

$PEPE

$POPCAT

$WIF

'Pepe's Best Friend' Brett Guns For Shiba Inu's, Dogecoin's Rival Dogwifhat With 14% And Coinbase Listing Speculation

RBC Capital analyst Ben Hendrix reiterates Ardent Health Partners (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARDT#NYSE">ARDT</a>) with a Outperform and maintains $23 price target.

ARDT

RBC Capital Reiterates Outperform on Ardent Health Partners, Maintains $23 Price Target

STRO

Sutro Biopharma shares are trading lower after the company reported worse-than-expected Q3 sales results.

RBC Capital analyst Kenneth Lee maintains Cannae Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNNE#NYSE">CNNE</a>) with a Outperform and raises the price target from $26 to $27.

CNNE

RBC Capital Maintains Outperform on Cannae Holdings, Raises Price Target to $27

Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myeloma
<ul>
<li>Recommendation based on IMROZ phase 3 study demonstrating Sarclisa in combination with VRd significantly improved progression-free survival, compared to standard-of-care VRd alone</li>
<li>If approved, Sarclisa would be the first anti-CD38 therapy in the EU available for use in combination with VRd for adult patients with transplant-ineligible NDMM</li>
</ul>
 Paris, November 14, 2024. The European Medicines Agency (EMA)'s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Sarclisa in combination with bortezomib, lenalidomide, and dexamethasone (VRd) for the treatment of adult patients with newly diagnosed multiple myeloma (NDMM) who are ineligible for autologous stem cell transplant (ASCT). A final decision is expected in the coming months.

Biotech

General

Sarclisa Recommended For EU Approval By The CHMP To Treat Transplant-Ineligible Newly Diagnosed Multiple Myeloma; Sarclisa Recommended For EU Approval By CHMP; Sarclisa Could Be First Anti-CD38 Therapy In EU For NDMM

Bitcoin Eyes A Breakout, Have The Stars Finally Aligned?

VanEck Mid-October Bitcoin ChainCheck

Markets Weekly Outlook - PMI Data And IMF Meeting Dominate The Agenda

Are New Highs Ahead For Bitcoin?

Bitcoin Takes A Pause, $75k Still On As OTC Inflows Decline

Trump's Decisive Victory: Market Reactions And Economic Implications

Monthly Market Recap: Post-Election Positioning

Bitcoin Price Surge Driven By Strategic Reserve Accumulation

Politics, Central Banks, And What Matters Most To Markets

Bitcoin's Bull Run: On-Chain Data Signals New Demand, $100k In Sight?

ACSI

ACTV

ACVF

AESR

AFLG

AFMC

AFSM

AGGY

APRT

APRW

ARKB

ARKK

ASHR

ASHS

AVIG

AVUS

AVUV

BAPR

BBAG

BBCA

BBEU

BBJP

BBSC

BBUS

BCHG

BIBL

BITB

BITO

BKAG

BKLC

BKMC

BKSE

BMAR

BMAY

BMVP

BNDC

BRRR

BTCO

BTCW

BTGD

BUZZ

BWVTF

CALF

CATH

CBSE

CHGX

CHIQ

CMBS

CNXT

CNYA

CQQQ

CXSE

DBEU

DBEZ

DBJP

DEEP

DEFI

DEMZ

DEUS

DFAS

DFAU

DGRS

DGRW

DSTL

DUSA

DVOL

DWAS

DXJS

DYNF

EAGG

ECNS

EFIV

ENZL

EQAL

EQWL

ESGA

ESGU

ESGV

ESGY

ESML

EUDG

EUDV

EURL

EUSA

EUSC

EWJV

EWUS

EZBC

FBTC

FCPI

FCTR

FDLO

FEUZ

FFIU

FIBR

FIGB

FLAU

FLCA

FLCB

FLEE

FLEU

FLGB

FLHK

FLJH

FLJP

FLQM

FLQS

FNDA

FPXE

FSCS

FSEC

FSMD

FTDS

FTSD

GBIL

GBTC

GCOR

GLDI

GLDM

Comments

GRAYSCALE BITCOIN CASH TR by Grayscale Bitcoin Cash Trust (BCH)

Notizie

Ultime notizie per GRAYSCALE BITCOIN CASH TR by Grayscale Bitcoin Cash Trust (BCH) (OTC:BCHG) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO